Not Applicable

Manufacturer
Sterling-Knight Pharmaceuticals, LLC
Effective date
2020-02-18
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:32:19

Label at a glance#

ProductNot Applicable
Active ingredientUrea
Label structure13 sections

Indications and uses

This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.

Dosage and administration

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

Label contents#

Full prescribing information#

DESCRIPTION:

DESCRIPTION SECTION

Protexa Cream (42% Urea) is a keratolytic emollient which is gentle, yet potent, tissue softener for nails and/or skin. Each gram contains 42% Urea, Water, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Glycerin, Ceteary Alcohol, Polysorbate 60, Dimethicone, C12-15 Alkyl Benzoate, Glyceryl Stearate, PEG-100 Stearate, Propylene Glycol, Aloe Barbadensis Leaf Juice Powder, Phenoxyethanol, Ethylhexylglycerin, Xanthan Gum, Citric Acid. Urea Urea is a diamide of carbonic acid with the following chemical structure:

chemicalstructurechemicalstructure

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.
Pharmacokinetics: The mechanism of action of topically applied urea is not yet known.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product

WARNINGS:

WARNINGS SECTION

KEEP OUT OF REACH OF CHILDREN.
PRECAUTIONS: FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.
General:
This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

Information for Patients:

INFORMATION FOR PATIENTS SECTION

Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes.
Carcinogenesis, Mutagenesis and Impairment of Fertility: Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

Pregnancy:

PREGNANCY SECTION

Category C.
Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.
CALL YOUR DOCTOR ABOUT SIDE EFFECTS.
Call your doctor about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

HOW SUPPLIED:

HOW SUPPLIED SECTION

Protexa Cream (42% Urea) is available as follows: 45g container, NDC 69336-810-45

KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on the therapeutic equivalence.

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. Protect from freezing and excessive heat. Keep bottle tightly closed.

Distributed By:
Sterling-Knight Pharmaceuticals, LLC
Ripley, MS 38663

Item: 810                                           Rev. 09/19

Protexa Urea 42% Cream - Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

protexalabelprotexalabel

Protexa Urea 42% Cream - Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

protexacartonprotexacarton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69336-810-452022-01-28C16284748780-1d6a99b39-876a-a426-e053-dadaa90af4c2Protexa Urea 42% CreamRx Only FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69336-810-45Not Applicable1 in 1 CARTONCREAM12
69336-810-45Not Applicable45 g in 1 CONTAINERCREAM452

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69336-810NOT APPLICABLE (PROTEXA) CREAM [STERLING-KNIGHT PHARMACEUTICALS, LLC]2Legacy NDC, 2 package rows20200219_78f23668-5590-4a4e-9547-272ddc70af3a.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69336-81069336-810-45

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
54990261-8036-41f2-b58b-e1dd0aac2e1678f23668-5590-4a4e-9547-272ddc70af3a2020-02-18Warnings, Adverse reactionsExact identifier
spl id: 54990261-8036-41f2-b58b-e1dd0aac2e16
spl set id: 78f23668-5590-4a4e-9547-272ddc70af3a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.